emtricitabine - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle
AUST R: 265834
Active ingredients:
emtricitabine
tenofovir disoproxil maleate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
20 May 2024
to
31 Jul 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic products are available.
TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ Viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle
AUST R: 280721
Active ingredients:
efavirenz
emtricitabine
tenofovir disoproxil maleate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
20 Mar 2025
to
31 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.
CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
AUST R: 327898
Active ingredients:
emtricitabine
tenofovir disoproxil fumarate

Dosage form:
Tablet, film coated

Sponsor:
Cipla Australia Pty Ltd

Phone:
0396964413

From
01 Mar 2025
to
07 May 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing